With the analysis among 3,895 patents, we discovered top 470 key players by total patent application. Dyne Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., Bristol Myers Squibb Co. are dominant in this area. They take 8.78% of the total patent filing.
Massachusetts, United States
Patent: 153
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 117
New York, United States
Patent: 72
Pierre Fabre Médicament SAS
Molecular Templates, Inc.
Texas, United States
Patent: 58
New Jersey, United States
Patent: 53
Ontario, Canada
Patent: 42
Akershus, Norway
Patent: 35
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 30
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 29
With the analysis among 93 patents, we discovered top 16 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Orum Therapeutics, Inc., Lycia Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 10
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 8
Zuid-Holland, Netherlands
Patent: 6
Jiangsu Sheng, China
Patent: 5
California, United States
Patent: 4
Sachsen-Anhalt, Germany
Patent: 3
Cambridgeshire, United Kingdom
Patent: 2
With the analysis among related 1,673 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Dyne Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., Daiichi Sankyo Co., Ltd. take 16.56% of patent filing during this period.
Massachusetts, United States
Patent: 153
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 72
New Jersey, United States
Patent: 52
New York, United States
Patent: 27
Nordrhein-Westfalen, Germany
Patent: 26
Regents of the University of California
California, United States
Patent: 22
Molecular Templates, Inc.
Texas, United States
Patent: 20
Washington, United States
Patent: 14
Purdue Research Foundation
Indiana, United States
Patent: 13
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 11
With the analysis among related 1,673 patents in last 5 years, we discover 412 new entrants. Dyne Therapeutics, Inc., Bayer AG, Mabwell (Shanghai) Bioscience Co., Ltd. are the most active new entrants in this area.
Massachusetts, United States
Patent: 153
Nordrhein-Westfalen, Germany
Patent: 26
Mabwell (Shanghai) Bioscience Co., Ltd.
Shanghai Shi, China
Patent: 10
California, United States
Patent: 10
Shanghai Henlius Biotech, Inc.
Shanghai Shi, China
Patent: 8
Sumgen Monoclonal Antibody (Beijing) Biotechnology Co Ltd
Beijing Shi, China
Patent: 8
Shanghai Henlius Biopharmaceuticals Co. , Ltd.
Shanghai Shi, China
Patent: 8
Shanghai Henlius Biologics Co., Ltd.
Shanghai Shi, China
Patent: 8
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 8
Harbour BioMed (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 7
With the analysis among 1,076 patents, we discovered top 230 universities and scientific research institutions by total patent application. University of Connecticut, Massachusetts Institute of Technology, The University of North Carolina at Chapel Hill are dominant in this area. They take 15.61% of the total patent filing.
University of Connecticut
Connecticut, United States
Patent: 42
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 25
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 25
President & Fellows of Harvard College
Massachusetts, United States
Patent: 13
North Carolina, United States
Patent: 12
Louisiana State University
Louisiana, United States
Patent: 12
Tokyo-to, Japan
Patent: 12
The Curators of the University of Missouri
Missouri, United States
Patent: 11
University of Southern California
California, United States
Patent: 9